New nasal spray enters first human tests for stubborn sinus condition
Disease control
Recruiting now
This is an early-stage study to first check if a new nasal spray called VVN432 is safe and how it behaves in the body. It will be tested first in healthy volunteers and then in people with chronic sinusitis. The main goal is to understand the spray's safety profile and how it is …
Phase: PHASE1 • Sponsor: VivaVision Biotech, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC